2018
DOI: 10.1021/acs.biomac.8b01429
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Evidence for Use of a Noninvasive Biosensor for Tear Glucose as an Alternative to Painful Finger-Prick for Diabetes Management Utilizing a Biopolymer Coating

Abstract: Diabetes is a metabolic condition that is exponentially increasing worldwide. Current monitoring methods for diabetes are invasive, painful, and expensive. Herein, we present the first multipatient clinical trial that demonstrates clearly that tear fluid may be a valuable marker for systemic glucose measurements. The NovioSense Glucose Sensor, worn under the lower eye lid (inferior conjunctival fornix), is reported to continuously measure glucose levels in the basal tear fluid with good correlation to blood gl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
114
0
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 128 publications
(117 citation statements)
references
References 30 publications
1
114
0
2
Order By: Relevance
“…Given these challenges, it may seem that dielectric spectroscopy is unsuitable for the task at hand. Indeed, with the decision to suspend activities into a smart contact lens for glucose monitoring by Verily (part of Alphabet, owner of Google) [85], the dream of non-invasive monitoring may seem unachievable (although the early work by Noviosense, which also works with tears and notably uses an enzyme-based approach to achieve selectivity, offers some hope [9,86]). Rather than concede this, we have suggested avenues for further exploration that may enable true non-invasive, continuous monitoring of blood glucose levels to be achieved.…”
Section: Discussionmentioning
confidence: 99%
“…Given these challenges, it may seem that dielectric spectroscopy is unsuitable for the task at hand. Indeed, with the decision to suspend activities into a smart contact lens for glucose monitoring by Verily (part of Alphabet, owner of Google) [85], the dream of non-invasive monitoring may seem unachievable (although the early work by Noviosense, which also works with tears and notably uses an enzyme-based approach to achieve selectivity, offers some hope [9,86]). Rather than concede this, we have suggested avenues for further exploration that may enable true non-invasive, continuous monitoring of blood glucose levels to be achieved.…”
Section: Discussionmentioning
confidence: 99%
“…[33] The stains on the chip are the preloaded indicators.When a4.8 mL droplet containing metal ions over the concentration of the ppm scale was dripped on the chip,i tw as divided into five microdroplets and reacted with the indicators in the sensing zones.T he specific colors in these sensing zones indicate the existence of Ni 2+ ,C u 2+ ,o rC r 6+ ions and the acidity of the sample.T his strategy can be extended to the multianalyte detection of biosamples,s uch as tears,b lood, and urine. [34,35]…”
Section: Resultsmentioning
confidence: 99%
“…Glucose sensors have also been made for implantation in the eye and bladder [ 82 , 83 , 84 , 85 , 86 , 87 ]. This is a good measure of glucose in the body, but there is a delay in the change compared to blood.…”
Section: Long Term Implantsmentioning
confidence: 99%
“…This is a good measure of glucose in the body, but there is a delay in the change compared to blood. An example of a glucose sensor for the eye is given in Figure 18 [ 86 ]. This approach is less invasive than the implanted approach.…”
Section: Long Term Implantsmentioning
confidence: 99%